Epigenetic gene regulation in stem cells and correlation to cancer

Differentiation

Volumn 78, Issue 1, 2009, Pages 1-17

  Mathews, Lesley A ^a   Crea, Francesco ^b   Farrar, W L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Embryonic stem cells; Epigenetics; Normal and cancerous adult stem progenitor cells

Indexed keywords

BCR ABL PROTEIN; CD24 ANTIGEN; CD34 ANTIGEN; CD44V ANTIGEN; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE INHIBITOR; GENOMIC DNA; GLUTATHIONE TRANSFERASE P1; HISTONE; HISTONE DEACETYLASE INHIBITOR; HOX PROTEIN; RETINOIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR MSX1; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR NKX3.1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; BRAIN TUMOR; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL RENEWAL; CHROMATIN STRUCTURE; CHRONIC MYELOID LEUKEMIA; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; DRUG MECHANISM; EMBRYONIC STEM CELL; EPIGENETICS; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TRANSLOCATION; GENETIC CORRELATION; GENETIC REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; KIDNEY CARCINOMA; KIDNEY CELL; LEUKEMIA; LIVER CELL; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; NEURAL STEM CELL; NEUROEPITHELIUM; NONHUMAN; PANCREAS CANCER; PANCREAS CELL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DNA BINDING; REVIEW; RNA INTERFERENCE;

DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENE SILENCING; HISTONES; HUMANS; MODELS, GENETIC; NEOPLASMS; STEM CELLS;

RODENTIA;

EID: 67649397334     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2009.04.002     Document Type: Review

References (192)

1. Aapola U., Kawasaki K., Scott H.S., Ollila J., Vihinen M., Heino M., Shintani A., Kawasaki K., Minoshima S., Krohn K., Antonarakis S.E., Shimizu N., Kudoh J., and Peterson P. Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. Genomics 65 (2000) 293-298
2. Abramovich C., and Humphries R.K. Hox regulation of normal and leukemic hematopoietic stem cells. Current Opinion in Hematology 12 (2005) 210-216
3. Addla S.K., Brown M.D., Hart C.A., Ramani V.A., and Clarke N.W. Characterization of the Hoechst33342 side population from normal and malignant human renal epithelial cells. American Journal Physiology-Renal Physiology. (2008)
4. Adkins N.L., Watts M., and Georgel P.T. To the 30-nm chromatin fiber and beyond. Biochimica et Biophysica Acta 1677 (2004) 12-23
5. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 3983-3988
6. Alberts B. Essential Cell Biology (2004), Garland Science Pub., New York, NY
7. Allegrucci C., Thurston A., Lucas E., and Young L. Epigenetics and the germline. Reproduction 129 (2005) 137-149
8. Allegrucci C., and Young L.E. Differences between human embryonic stem cell lines. Human Reproduction Update 13 (2007) 103-120
9. Allis C., Jenuwein T., and Reinberg D. Epigenetics (2007), Cold Spring Harbor Laboratory Press, New York
10. Anbazhagan R., Osin P.P., Bartkova J., Nathan B., Lane E.B., and Gusterson B.A. The development of epithelial phenotypes in the human fetal and infant breast. The Journal of Pathology 184 (1998) 197-206
11. Arinobu Y., Mizuno S., Chong Y., Shigematsu H., Iino T., Iwasaki H., Graf T., Mayfield R., Chan S., Kastner P., and Akashi K. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages. Cell Stem Cell 1 (2007) 416-427
12. Atkinson S., and Armstrong L. Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation. Cell and Tissue Research 331 (2008) 23-29
13. Ballas N., and Mandel G. The many faces of REST oversee epigenetic programming of neuronal genes. Current Opinion in Neurobiology 15 (2005) 500-506
14. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., and Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 129 (2007) 823-837
15. Baum C.M., Weissman I.L., Tsukamoto A.S., Buckle A.M., and Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 2804-2808
16. Beier D., Hau P., Proescholdt M., Lohmeier A., Wischhusen J., Oefner P.J., Aigner L., Brawanski A., Bogdahn U., and Beier C.P. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Research 67 (2007) 4010-4015
17. Beier D., Rohrl S., Pillai D.R., Schwarz S., Kunz-Schughart L.A., Leukel P., Proescholdt M., Brawanski A., Bogdahn U., Trampe-Kieslich A., Giebel B., Wischhusen J., Reifenberger G., Hau P., and Beier C.P. Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Research 68 (2008) 5706-5715
18. Bernstein B.E., Kamal M., Lindblad-Toh K., Bekiranov S., Bailey D.K., Huebert D.J., McMahon S., Karlsson E.K., Kulbokas III E.J., Gingeras T.R., Schreiber S.L., and Lander E.S. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120 (2005) 169-181
19. Bestor T.H., and Ingram V.M. Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA. Proceedings of the National Academy of Sciences of the United States of America 80 (1983) 5559-5563
20. Bird A., Taggart M., Frommer M., Miller O.J., and Macleod D. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 40 (1985) 91-99
21. Bonkhoff H., and Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. The Prostate 28 (1996) 98-106
22. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 3 (1997) 730-737
23. Boyer L.A., Plath K., Zeitlinger J., Brambrink T., Medeiros L.A., Lee T.I., Levine S.S., Wernig M., Tajonar A., Ray M.K., Bell G.W., Otte A.P., Vidal M., Gifford D.K., Young R.A., and Jaenisch R. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441 (2006) 349-353
24. Bracken A.P., Pasini D., Capra M., Prosperini E., Colli E., and Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. The EMBO Journal 22 (2003) 5323-5335
25. Brisken C. Hormonal control of alveolar development and its implications for breast carcinogenesis. Journal of Mammary Gland Biology and Neoplasia 7 (2002) 39-48
26. Cameron E.E., Bachman K.E., Myohanen S., Herman J.G., and Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nature Genetics 21 (1999) 103-107
27. Candelaria M., Gallardo-Rincon D., Arce C., Cetina L., Aguilar-Ponce J.L., Arrieta O., Gonzalez-Fierro A., Chavez-Blanco A., de la Cruz-Hernandez E., Camargo M.F., Trejo-Becerril C., Perez-Cardenas E., Perez-Plasencia C., Taja-Chayeb L., Wegman-Ostrosky T., Revilla-Vazquez A., and Duenas-Gonzalez A. A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors. Annals of Oncology 18 (2007) 1529-1538
28. Cariati M., and Purushotham A.D. Stem cells and breast cancer. Histopathology 52 (2008) 99-107
29. Chalandon Y., Jiang X., Christ O., Loutet S., Thanopoulou E., Eaves A., and Eaves C. BCR-ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice. Leukemia 19 (2005) 442-448
30. Cheng A.S., Culhane A.C., Chan M.W., Venkataramu C.R., Ehrich M., Nasir A., Rodriguez B.A., Liu J., Yan P.S., Quackenbush J., Nephew K.P., Yeatman T.J., and Huang T.H. Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Research 68 (2008) 1786-1796
31. Chuang J.C., and Jones P.A. Epigenetics and microRNAs. Pediatric Research 61 (2007) 24R-29R
32. Chung L.W., Hsieh C.L., Law A., Sung S.Y., Gardner T.A., Egawa M., Matsubara S., and Zhau H.E. New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions. Urology 62 (2003) 44-54
33. Clarke M.F. A self-renewal assay for cancer stem cells. Cancer Chemotherapy and Pharmacology 56 Suppl. 1 (2005) 64-68
34. Clarkson B., Strife A., Wisniewski D., Lambek C.L., and Liu C. Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies. Leukemia 17 (2003) 1211-1262
35. Conaco C., Otto S., Han J.J., and Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 2422-2427
36. Cox D.N., Chao A., and Lin H. piwi encodes a nucleoplasmic factor whose activity modulates the number and division rate of germline stem cells. Development (Cambridge, England) 127 (2000) 503-514
37. Cozzio A., Passegue E., Ayton P.M., Karsunky H., Cleary M.L., and Weissman I.L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes & Development 17 (2003) 3029-3035
38. Crosby H.A., Kelly D.A., and Strain A.J. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology 120 (2001) 534-544
39. De Marzo A.M., Meeker A.K., Epstein J.I., and Coffey D.S. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. The American Journal of Pathology 153 (1998) 911-919
40. Deome K.B., Faulkin Jr. L.J., Bern H.A., and Blair P.B. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Research 19 (1959) 515-520
41. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 21 (2002) 5400-5413
42. Ema H., Morita Y., Yamazaki S., Matsubara A., Seita J., Tadokoro Y., Kondo H., Takano H., and Nakauchi H. Adult mouse hematopoietic stem cells: purification and single-cell assays. Nature Protocols 1 (2006) 2979-2987
43. Engelhardt M., Lubbert M., and Guo Y. CD34(+) or CD34(-): which is the more primitive?. Leukemia 16 (2002) 1603-1608
44. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
45. Fabian A., Barok M., Vereb G., and Szollosi J. Die hard: are cancer stem cells the Bruce Willises of tumor biology?. Cytometry A 75 (2009) 67-74
46. Faderl S., Talpaz M., Estrov Z., O'Brien S., Kurzrock R., and Kantarjian H.M. The biology of chronic myeloid leukemia. The New England Journal of Medicine 341 (1999) 164-172
47. Feinberg A.P. Phenotypic plasticity and the epigenetics of human disease. Nature 447 (2007) 433-440
48. Foshay K.M., and Gallicano G.I. Small RNAs, big potential: the role of MicroRNAs in stem cell function. Current Stem Cell Research and Therapy 2 (2007) 264-271
49. Frederiksen K., and McKay R.D. Proliferation and differentiation of rat neuroepithelial precursor cells in vivo. Journal of Neuroscience 8 (1988) 1144-1151
50. Gellon G., and McGinnis W. Shaping animal body plans in development and evolution by modulation of Hox expression patterns. Bioessays 20 (1998) 116-125
51. Gershengorn M.C., Hardikar A.A., Wei C., Geras-Raaka E., Marcus-Samuels B., and Raaka B.M. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 306 (2004) 2261-2264
52. Glinsky G.V. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management. Journal of Clinical Oncology. 26 (2008) 2846-2853
53. Graziano A., d'Aquino R., Tirino V., Desiderio V., Rossi A., and Pirozzi G. The stem cell hypothesis in head and neck cancer. Journal of Cellular Biochemistry 103 (2008) 408-412
54. Guenther M.G., Levine S.S., Boyer L.A., Jaenisch R., and Young R.A. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130 (2007) 77-88
55. Gupta S., and Rosenberg M.E. Do stem cells exist in the adult kidney?. American Journal of Nephrology 28 (2008) 607-613
56. Hadnagy A., Beaulieu R., and Balicki D. Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics. Molecular Cancer Therapeutics 7 (2008) 740-748
57. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., and Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1 (2007) 313-323
58. Hogg N.A., Harrison C.J., and Tickle C. Lumen formation in the developing mouse mammary gland. Journal of Embryology and Experimental Morphology 73 (1983) 39-57
59. Holliday R., and Pugh J.E. DNA modification mechanisms and gene activity during development. Science 187 (1975) 226-232
60. Hovey R.C., Trott J.F., and Vonderhaar B.K. Establishing a framework for the functional mammary gland: from endocrinology to morphology. Journal of Mammary Gland Biology and Neoplasia 7 (2002) 17-38
61. Hsieh J., Nakashima K., Kuwabara T., Mejia E., and Gage F.H. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 16659-16664
62. Huntly B.J., Shigematsu H., Deguchi K., Lee B.H., Mizuno S., Duclos N., Rowan R., Amaral S., Curley D., Williams I.R., Akashi K., and Gilliland D.G. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer cell 6 (2004) 587-596
63. Hurt E.M., Kawasaki B.T., Klarmann G.J., Thomas S.B., and Farrar W.L. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. British Journal of Cancer 98 (2008) 756-765
64. Inowa T., Hishikawa K., Takeuchi T., Kitamura T., and Fujita T. Isolation and potential existence of side population cells in adult human kidney. International Journal of Urology 15 (2008) 272-274
65. Ivascu C., Wasserkort R., Lesche R., Dong J., Stein H., Thiel A., and Eckhardt F. DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas. The International Journal of Biochemistry & Cell Biology 39 (2007) 1523-1538
66. Jarrard D.F., Kinoshita H., Shi Y., Sandefur C., Hoff D., Meisner L.F., Chang C., Herman J.G., Isaacs W.B., and Nassif N. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Cancer Research 58 (1998) 5310-5314
67. Jensen J.B., and Parmar M. Strengths and limitations of the neurosphere culture system. Molecular Neurobiology 34 (2006) 153-161
68. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
69. Jones P.A., and Takai D. The role of DNA methylation in mammalian epigenetics. Science 293 (2001) 1068-1070
70. Jowett A.K., Vainio S., Ferguson M.W., Sharpe P.T., and Thesleff I. Epithelial-mesenchymal interactions are required for msx 1 and msx 2 gene expression in the developing murine molar tooth. Development 117 (1993) 461-470
71. Kale S., Karihaloo A., Clark P.R., Kashgarian M., Krause D.S., and Cantley L.G. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. Journal of Clinical Investigation 112 (2003) 42-49
72. Kaminskas E., Farrell A., Abraham S., Baird A., Hsieh L.S., Lee S.L., Leighton J.K., Patel H., Rahman A., Sridhara R., Wang Y.C., and Pazdur R. Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes. Clinical Cancer Research 11 (2005) 3604-3608
73. Kantarjian H., Issa J.P., Rosenfeld C.S., Bennett J.M., Albitar M., DiPersio J., Klimek V., Slack J., de Castro C., Ravandi F., Helmer III R., Shen L., Nimer S.D., Leavitt R., Raza A., and Saba H. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 106 (2006) 1794-1803
74. Kasper S. Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Reviews 4 (2008) 193-201
75. Kavalerchik E., Goff D., and Jamieson C.H. Chronic myeloid leukemia stem cells. Journal of Clinical Oncology 26 (2008) 2911-2915
76. Kawaji H., and Hayashizaki Y. Exploration of small RNAs. PLoS Genetics 4 (2008) e22
77. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes & Development 19 (2005) 1129-1155
78. Kinbara H., Cunha G.R., Boutin E., Hayashi N., and Kawamura J. Evidence of stem cells in the adult prostatic epithelium based upon responsiveness to mesenchymal inductors. The Prostate 29 (1996) 107-116
79. Klarmann G.J., Decker A., and Farrar W.L. Epigenetic gene silencing in the Wnt pathway in breast cancer. Epigenetics 3 (2008) 59-63
80. Klarmann G.J., Hurt E.M., Mathews L.A., Zhang X., Duhagon M.A., Mistree T., Thomas S.B., and Farrar W.L. Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clinical and Experimental Metastasis 3 (2009) 59-63
81. Koblas T., Pektorova L., Zacharovova K., Berkova Z., Girman P., Dovolilova E., Karasova L., and Saudek F. Differentiation of CD133-positive pancreatic cells into insulin-producing islet-like cell clusters. Transplantation Proceedings 40 (2008) 415-418
82. Koblas T., Zacharovova K., Berkova Z., Mindlova M., Girman P., Dovolilova E., Karasova L., and Saudek F. Isolation and characterization of human CXCR4-positive pancreatic cells. Folia Biologica 53 (2007) 13-22
83. Koch C.M., Andrews R.M., Flicek P., Dillon S.C., Karaoz U., Clelland G.K., Wilcox S., Beare D.M., Fowler J.C., Couttet P., James K.D., Lefebvre G.C., Bruce A.W., Dovey O.M., Ellis P.D., Dhami P., Langford C.F., Weng Z., Birney E., Carter N.P., Vetrie D., and Dunham I. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Research 17 (2007) 691-707
84. Kong Y., Yoshida S., Saito Y., Doi T., Nagatoshi Y., Fukata M., Saito N., Yang S.M., Iwamoto C., Okamura J., Liu K.Y., Huang X.J., Lu D.P., Shultz L.D., Harada M., and Ishikawa F. CD34+ CD38+ CD19+ as well as CD34+ CD38- CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia 22 (2008) 1207-1213
85. Kornberg R.D. Chromatin structure: a repeating unit of histones and DNA. Science 184 (1974) 868-871
86. Krivtsov A.V., and Armstrong S.A. MLL translocations, histone modifications and leukaemia stem-cell development. Nature Reviews 7 (2007) 823-833
87. Kucia M., Reca R., Jala V.R., Dawn B., Ratajczak J., and Ratajczak M.Z. Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia 19 (2005) 1118-1127
88. Kusano S., and Raab-Traub N. I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways. Molecular and Cellular Biology 22 (2002) 6393-6405
89. Kuzmanov A., Hayrabedyan S., Karaivanov M., and Todorova K. Basal cell subpopulation as putative human prostate carcinoma stem cells. Folia Histochemica et Cytobiologica/Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 45 (2007) 75-80
90. Kuzmichev A., Margueron R., Vaquero A., Preissner T.S., Scher M., Kirmizis A., Ouyang X., Brockdorff N., Abate-Shen C., Farnham P., and Reinberg D. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 1859-1864
91. Kuzmichev A., Nishioka K., Erdjument-Bromage H., Tempst P., and Reinberg D. Histone methyltransferase activity associated with a human multiprotein complex containing the enhancer of Zeste protein. Genes & Development 16 (2002) 2893-2905
92. Lagarkova M.A., Volchkov P.Y., Lyakisheva A.V., Philonenko E.S., and Kiselev S.L. Diverse epigenetic profile of novel human embryonic stem cell lines. Cell Cycle 5 (2006) 416-420
93. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., and Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
94. Lederer C.W., and Santama N. Neural stem cells: mechanisms of fate specification and nuclear reprogramming in regenerative medicine. Biotechnology Journal 3 (2008) 1521-1538
95. Lee C.J., Dosch J., and Simeone D.M. Pancreatic cancer stem cells. Journal of Clinical Oncology 26 (2008) 2806-2812
96. Lee W.J., and Kim H.J. Inhibition of DNA methylation is involved in transdifferentiation of myoblasts into smooth muscle cells. Molecules and Cells 24 (2007) 441-444
97. Lessard J., and Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423 (2003) 255-260
98. Li X., Barkho B.Z., Luo Y., Smrt R.D., Santistevan N.J., Liu C., Kuwabara T., Gage F.H., and Zhao X. Epigenetic regulation of the stem cell mitogen Fgf-2 by Mbd1 in adult neural stem/progenitor cells. The Journal of Biological Chemistry 283 (2008) 27644-27652
99. Liang J., Wan M., Zhang Y., Gu P., Xin H., Jung S.Y., Qin J., Wong J., Cooney A.J., Liu D., and Songyang Z. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nature Cell Biology 10 (2008) 731-739
100. Lindvall C., Bu W., Williams B.O., and Li Y. Wnt signaling, stem cells, and the cellular origin of breast cancer. Stem Cell Reviews 3 (2007) 157-168
101. Liu Y., and Rao M.S. Transdifferentiation-fact or artifact. Journal of Cellular Biochemistry 88 (2003) 29-40
102. Mahadevan D., Spier C., Della Croce K., Miller S., George B., Riley C., Warner S., Grogan T.M., and Miller T.P. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures. Molecular Cancer Therapeutics 4 (2005) 1867-1879
103. Maherali N., Sridharan R., Xie W., Utikal J., Eminli S., Arnold K., Stadtfeld M., Yachechko R., Tchieu J., Jaenisch R., Plath K., and Hochedlinger K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1 (2007) 55-70
104. Mahlknecht U., and Schonbein C. Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells. Haematologica 93 (2008) 443-446
105. Mann J., Oakley F., Akiboye F., Elsharkawy A., Thorne A.W., and Mann D.A. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death and Differentiation 14 (2007) 275-285
106. Matushansky I., Radparvar F., Rekhtman N., and Skoultchi A. Reprogramming erythroleuekmia cells to terminal differentiation and terminal cell division. Frontiers in Bioscience 5 (2000) D488-D492
107. Metcalf D. Concise review: hematopoietic stem cells and tissue stem cells: current concepts and unanswered questions. Stem Cells (Dayton, Ohio) 25 (2007) 2390-2395
108. Metsuyanim S., Pode-Shakked N., Schmidt-Ott K.M., Keshet G., Rechavi G., Blumental D., and Dekel B. Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes. Stem Cells 26 (2008) 1808-1817
109. Milne T.A., Martin M.E., Brock H.W., Slany R.K., and Hess J.L. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications. Cancer Research 65 (2005) 11367-11374
110. Mimeault M., and Batra S.K. Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer. Gut 57 (2008) 1456-1468
111. Mishra L., Banker T., Murray J., Byers S., Thenappan A., He A.R., Shetty K., Johnson L., and Reddy E.P. Liver stem cells and hepatocellular carcinoma. Hepatology (Baltimore, MD) 49 (2009) 318-329
112. Mohinta S., Wu H., Chaurasia P., and Watabe K. Wnt pathway and breast cancer. Frontiers in Bioscience 12 (2007) 4020-4033
113. Mohty M., Yong A.S., Szydlo R.M., Apperley J.F., and Melo J.V. The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia. Blood 110 (2007) 380-383
114. Morest D.K., and Silver J. Precursors of neurons, neuroglia, and ependymal cells in the CNS: what are they? Where are they from? How do they get where they are going?. Glia 43 (2003) 6-18
115. Morris M.R., Gentle D., Abdulrahman M., Clarke N., Brown M., Kishida T., Yao M., Teh B.T., Latif F., and Maher E.R. Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma. British Journal of Cancer 98 (2008) 496-501
116. Morrison S.J., White P.M., Zock C., and Anderson D.J. Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 96 (1999) 737-749
117. Mueller B.U., Pabst T., Fos J., Petkovic V., Fey M.F., Asou N., Buergi U., and Tenen D.G. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood 107 (2006) 3330-3338
118. Mutskov V., Raaka B.M., Felsenfeld G., and Gershengorn M.C. The human insulin gene displays transcriptionally active epigenetic marks in islet-derived mesenchymal precursor cells in the absence of insulin expression. Stem Cells 25 (2007) 3223-3233
119. Nakafuku M., Nagao M., Grande A., and Cancelliere A. Revisiting neural stem cell identity. Proceedings of the National Academy of Sciences of the United States of America 105 (2008) 829-830
120. Nakayama T., Watanabe M., Suzuki H., Toyota M., Sekita N., Hirokawa Y., Mizokami A., Ito H., Yatani R., and Shiraishi T. Epigenetic regulation of androgen receptor gene expression in human prostate cancers. Laboratory Investigation; a Journal of Technical Methods and Pathology 80 (2000) 1789-1796
121. Namihira M., Kohyama J., Abematsu M., and Nakashima K. Epigenetic mechanisms regulating fate specification of neural stem cells. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 363 (2008) 2099-2109
122. Okano M., Xie S., and Li E. Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Research 26 (1998) 2536-2540
123. Otte A.P., and Kwaks T.H. Gene repression by Polycomb group protein complexes: a distinct complex for every occasion?. Current Opinion in Genetics and Development 13 (2003) 448-454
124. Pal S., and Sif S. Interplay between chromatin remodelers and protein arginine methyltransferases. Journal of Cellular Physiology 213 (2007) 306-315
125. Pallini R., Ricci-Vitiani L., Banna G.L., Signore M., Lombardi D., Todaro M., Stassi G., Martini M., Maira G., Larocca L.M., and De Maria R. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clinical Cancer Research 14 (2008) 8205-8212
126. Pan G., Tian S., Nie J., Yang C., Ruotti V., Wei H., Jonsdottir G.A., Stewart R., and Thomson J.A. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 1 (2007) 299-312
127. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., and Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451 (2008) 141-146
128. Passegue E., and Weissman I.L. Leukemic stem cells: where do they come from?. Stem Cell Reviews 1 (2005) 181-188
129. Pelissier T., and Wassenegger M. A DNA target of 30 bp is sufficient for RNA-directed DNA methylation. RNA 6 (2000) 55-65
130. Perry A.S., Foley R., Woodson K., and Lawler M. The emerging roles of DNA methylation in the clinical management of prostate cancer. Endocrine-Related Cancer 13 (2006) 357-377
131. Pietersen A.M., Evers B., Prasad A.A., Tanger E., Cornelissen-Steijger P., Jonkers J., and van Lohuizen M. Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Current Biology 18 (2008) 1094-1099
132. Porter R.L., and Calvi L.M. Communications between bone cells and hematopoietic stem cells. Archives of Biochemistry and Biophysics 473 (2008) 193-200
133. Preston S.L., Alison M.R., Forbes S.J., Direkze N.C., Poulsom R., and Wright N.A. The new stem cell biology: something for everyone. Molecular Pathology 56 (2003) 86-96
134. Prins G.S., and Birch L. The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 136 (1995) 1303-1314
135. Radich J.P., Dai H., Mao M., Oehler V., Schelter J., Druker B., Sawyers C., Shah N., Stock W., Willman C.L., Friend S., and Linsley P.S. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 2794-2799
136. Reik W., Collick A., Norris M.L., Barton S.C., and Surani M.A. Genomic imprinting determines methylation of parental alleles in transgenic mice. Nature 328 (1987) 248-251
137. Rice K.L., Hormaeche I., and Licht J.D. Epigenetic regulation of normal and malignant hematopoiesis. Oncogene 26 (2007) 6697-6714
138. Riggs A.D. X inactivation, differentiation, and DNA methylation. Cytogenetics and Cell Genetics 14 (1975) 9-25
139. Robinson D.R., Zylstra C.R., and Williams B.O. Wnt signaling and prostate cancer. Current Drug Targets 9 (2008) 571-580
140. Rodriguez R.T., Velkey J.M., Lutzko C., Seerke R., Kohn D.B., O'Shea K.S., and Firpo M.T. Manipulation of OCT4 levels in human embryonic stem cells results in induction of differential cell types. Experimental Biology and Medicine (Maywood) 232 (2007) 1368-1380
141. Rossi D.J., Seita J., Czechowicz A., Bhattacharya D., Bryder D., and Weissman I.L. Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle (Georgetown, Tex) 6 (2007) 2371-2376
142. Rugg-Gunn P.J., Ferguson-Smith A.C., and Pedersen R.A. Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. Human Molecular Genetics 16 Spec No. 2 (2007) R243-R251
143. Sato N., Fukushima N., Matsubayashi H., and Goggins M. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene 23 (2004) 1531-1538
144. Sato N., and Goggins M. The role of epigenetic alterations in pancreatic cancer. Journal of Hepatobiliary Pancreatic Surgery 13 (2006) 286-295
145. Scharenberg C.W., Harkey M.A., and Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99 (2002) 507-512
146. Schoenherr C.J., Paquette A.J., and Anderson D.J. Identification of potential target genes for the neuron-restrictive silencer factor. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 9881-9886
147. Sciavolino P.J., Abrams E.W., Yang L., Austenberg L.P., Shen M.M., and Abate-Shen C. Tissue-specific expression of murine Nkx3.1 in the male urogenital system. Developmantal Dynamics 209 (1997) 127-138
148. Sell S. Stem cell origin of cancer and differentiation therapy. Critical Review in Oncology/Hematology 51 (2004) 1-28
149. Shi Y. Histone lysine demethylases: emerging roles in development, physiology and disease. Nature Reviews. Genetics 8 (2007) 829-833
150. Sieburg H.B., Cho R.H., and Muller-Sieburg C.E. Limiting dilution analysis for estimating the frequency of hematopoietic stem cells: uncertainty and significance. Experimental Hematology 30 (2002) 1436-1443
151. Sigal S.H., Brill S., Reid L.M., Zvibel I., Gupta S., Hixson D., Faris R., and Holst P.A. Characterization and enrichment of fetal rat hepatoblasts by immunoadsorption ("panning") and fluorescence-activated cell sorting. Hepatology (Baltimore, MD) 19 (1994) 999-1006
152. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., and Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Research 63 (2003) 5821-5828
153. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
154. Singh S.K., Kagalwala M.N., Parker-Thornburg J., Adams H., and Majumder S. REST maintains self-renewal and pluripotency of embryonic stem cells. Nature 453 (2008) 223-227
155. Sirard C., Lapidot T., Vormoor J., Cashman J.D., Doedens M., Murdoch B., Jamal N., Messner H., Addey L., Minden M., Laraya P., Keating A., Eaves A., Lansdorp P.M., Eaves C.J., and Dick J.E. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87 (1996) 1539-1548
156. Smith G.H., and Medina D. A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. Journal of Cell Science 90 Pt 1 (1988) 173-183
157. Steger D.J., Lefterova M.I., Ying L., Stonestrom A.J., Schupp M., Zhuo D., Vakoc A.L., Kim J.E., Chen J., Lazar M.A., Blobel G.A., and Vakoc C.R. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Molecular Cell Biology 28 (2008) 2825-2839
158. Stein T., Price K.N., Morris J.S., Heath V.J., Ferrier R.K., Bell A.K., Pringle M.A., Villadsen R., Petersen O.W., Sauter G., Bryson G., Mallon E.A., and Gusterson B.A. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer. Clinical Cancer Research 11 (2005) 6872-6879
159. Stopka T., Amanatullah D.F., Papetti M., and Skoultchi A.I. PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure. The EMBO Journal 24 (2005) 3712-3723
160. Su X., Gopalakrishnan V., Stearns D., Aldape K., Lang F.F., Fuller G., Snyder E., Eberhart C.G., and Majumder S. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation. Molecular and Cellular Biology 26 (2006) 1666-1678
161. Suetsugu A., Nagaki M., Aoki H., Motohashi T., Kunisada T., and Moriwaki H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochemical and Biophysical Research Communications 351 (2006) 820-824
162. Suh M.R., Lee Y., Kim J.Y., Kim S.K., Moon S.H., Lee J.Y., Cha K.Y., Chung H.M., Yoon H.S., Moon S.Y., Kim V.N., and Kim K.S. Human embryonic stem cells express a unique set of microRNAs. Developmental Biology 270 (2004) 488-498
163. Suzuki A., and Nakauchi H. Identification and propagation of liver stem cells. Seminars in Cell & Developmental Biology 13 (2002) 455-461
164. Suzuki A., Zheng Y.W., Kaneko S., Onodera M., Fukao K., Nakauchi H., and Taniguchi H. Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. Journal of Cell Biology 156 (2002) 173-184
165. Suzuki M., Yamada T., Kihara-Negishi F., Sakurai T., Hara E., Tenen D.G., Hozumi N., and Oikawa T. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. Oncogene 25 (2006) 2477-2488
166. Takaishi S., Okumura T., and Wang T.C. Gastric cancer stem cells. Journal of Clinical Oncology 26 (2008) 2876-2882
167. Tamura Y., Kataoka Y., Cui Y., Takamori Y., Watanabe Y., and Yamada H. Intracellular translocation of glutathione S-transferase pi during oligodendrocyte differentiation in adult rat cerebral cortex in vivo. Neuroscience 148 (2007) 535-540
168. Tang D.G., Patrawala L., Calhoun T., Bhatia B., Choy G., Schneider-Broussard R., and Jeter C. Prostate cancer stem/progenitor cells: identification, characterization, and implications. Molecular Carcinogenesis 46 (2007) 1-14
169. Terskikh A.V., Miyamoto T., Chang C., Diatchenko L., and Weissman I.L. Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood 102 (2003) 94-101
170. Tsai R.Y. A molecular view of stem cell and cancer cell self-renewal. The International Journal of Biochemistry & Cell Biology 36 (2004) 684-694
171. Uchida N., Aguila H.L., Fleming W.H., Jerabek L., and Weissman I.L. Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1lo Lin-Sca-1+ hematopoietic stem cells. Blood 83 (1994) 3758-3779
172. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., Tsukamoto A.S., Gage F.H., and Weissman I.L. Direct isolation of human central nervous system stem cells. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 14720-14725
173. Udani V.M. The continuum of stem cell transdifferentiation: possibility of hematopoietic stem cell plasticity with concurrent CD45 expression. Stem Cells Development 15 (2006) 1-3
174. Varambally S., Cao Q., Mani R.S., Shankar S., Wang X., Ateeq B., Laxman B., Cao X., Jing X., Ramnarayanan K., Brenner J.C., Yu J., Kim J.H., Han B., Tan P., Kumar-Sinha C., Lonigro R.J., Palanisamy N., Maher C.A., and Chinnaiyan A.M. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322 (2008) 1695-1699
175. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., Ghosh D., Pienta K.J., Sewalt R.G., Otte A.P., Rubin M.A., and Chinnaiyan A.M. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419 (2002) 624-629
176. Wagers A.J., Sherwood R.I., Christensen J.L., and Weissman I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297 (2002) 2256-2259
177. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., and Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369 (1994) 669-671
178. Wicha M.S., Liu S., and Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Research 66 (2006) 1883-1890 (discussion 1886-1895)
179. Wohrle S., Wallmen B., and Hecht A. Differential control of Wnt target genes involves epigenetic mechanisms and selective promoter occupancy by T-cell factors. Molecular Cell Biology 27 (2007) 8164-8177
180. Wolf S.F., Jolly D.J., Lunnen K.D., Friedmann T., and Migeon B.R. Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. Proceedings of the National Academy of Sciences of the United States of America 81 (1984) 2806-2810
181. Wright M.H., Calcagno A.M., Salcido C.D., Carlson M.D., Ambudkar S.V., and Varticovski L. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Research 10 (2008) R10
182. Wu A., Oh S., Wiesner S.M., Ericson K., Chen L., Hall W.A., Champoux P.E., Low W.C., and Ohlfest J.R. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties. Stem Cells Development 17 (2008) 173-184
183. Xie S., Wang Z., Okano M., Nogami M., Li Y., He W.W., Okumura K., and Li E. Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene 236 (1999) 87-95
184. Yamashita T., Ji J., Budhu A., Forgues M., Yang W., Wang H.Y., Jia H., Ye Q., Qin L.X., Wauthier E., Reid L.M., Minato H., Honda M., Kaneko S., Tang Z.Y., and Wang X.W. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136 (2008) 1012-1024
185. Yang M.Y., Liu T.C., Chang J.G., Lin P.M., and Lin S.F. JunB gene expression is inactivated by methylation in chronic myeloid leukemia. Blood 101 (2003) 3205-3211
186. Yi J.M., Tsai H.C., Glockner S.C., Lin S., Ohm J.E., Easwaran H., James C.D., Costello J.F., Riggins G., Eberhart C.G., Laterra J., Vescovi A.L., Ahuja N., Herman J.G., Schuebel K.E., and Baylin S.B. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Research 68 (2008) 8094-8103
187. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., Huang Y., Hu X., Su F., Lieberman J., and Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131 (2007) 1109-1123
188. Yu J., Yu J., Rhodes D.R., Tomlins S.A., Cao X., Chen G., Mehra R., Wang X., Ghosh D., Shah R.B., Varambally S., Pienta K.J., and Chinnaiyan A.M. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. Cancer Research 67 (2007) 10657-10663
189. Zaret K.S. Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation. Nature Reviews Genetics 9 (2008) 329-340
190. Zelent A., Petrie K., Boix-Chornet M., Melnick A.M., Waxman S., and Gore S.D. Derepression in the desert: the third workshop on clinical translation of epigenetics in cancer therapeutics. Cancer Research 68 (2008) 4967-4970
191. Zhang P., Behre G., Pan J., Iwama A., Wara-Aswapati N., Radomska H.S., Auron P.E., Tenen D.G., and Sun Z. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 8705-8710
192. Zhang P., Zhang X., Iwama A., Yu C., Smith K.A., Mueller B.U., Narravula S., Torbett B.E., Orkin S.H., and Tenen D.G. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 96 (2000) 2641-2648